细菌、病毒和真菌性皮肤感染的新进展
New Developments in Bacterial, Viral, and Fungal Cutaneous Infections.
作者信息
Yeroushalmi Samuel, Shirazi Joshua Yoseph, Friedman Adam
机构信息
1The George Washington University School of Medicine and Health Sciences, 2150 Pennsylvania Ave NW, Washington, DC 20037 USA.
2The University of Maryland, College Park, MD USA.
出版信息
Curr Dermatol Rep. 2020;9(2):152-165. doi: 10.1007/s13671-020-00295-1. Epub 2020 Mar 5.
PURPOSE OF REVIEW
This review highlights clinically relevant updates to common and significant bacterial, viral, and fungal cutaneous infection within the past 5 years. Recent developments are presented so that the clinician may provide evidence-based, high-quality patient care.
RECENT FINDINGS
New resistance patterns in cutaneous pathogens have recently emerged as a result of inappropriate antimicrobial use. Several new FDA-approved antimicrobials have been approved to treat such infections, including multi-drug resistant pathogens. Several organizational guidelines for cutaneous infection management have been updated with new recommendations for screening, diagnostic, and treatment strategies.
SUMMARY
Clinicians should be aware of the most recent evidence and guidelines for the management of cutaneous infections in order to reduce the emergence of antimicrobial resistance and most effectively treat their patients.
综述目的
本综述重点介绍过去5年常见且重要的细菌、病毒和真菌性皮肤感染的临床相关进展。展示近期的进展情况，以便临床医生能够提供基于证据的高质量患者护理。
最新发现
由于抗菌药物使用不当，皮肤病原体出现了新的耐药模式。美国食品药品监督管理局（FDA）已批准多种新型抗菌药物用于治疗此类感染，包括耐多药病原体。多项皮肤感染管理的组织指南已更新，其中包含筛查、诊断和治疗策略的新建议。
总结
临床医生应了解皮肤感染管理的最新证据和指南，以减少抗菌药物耐药性的出现，并最有效地治疗患者。
Zotero 插件